Andrew Zenoff v. Sorrento Therapeutics, Inc.

Good Law
97 F.4th 634
United States Court of Appeals for the Ninth CircuitMarch 25, 202422-55641California4,032 words

Opinion

Opinion

Callahan, J.

FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

In re: SORRENTO No. 22-55641

THERAPEUTICS, INC.

SECURITIES LITIGATION, D.C. Nos. ________________________________ 3:20-cv-00966-

AJB-DEB

ANDREW R. ZENOFF, Lead 3:20-cv-01066- Plaintiff, individually and on behalf of AJB-DEB all others similarly situated, 3:21-cv-01331-

AJB-DEB

Plaintiff-Appellant,

v. OPINION

SORRENTO THERAPEUTICS, INC.;

HENRY JI; MARK R. BRUNSWICK,

Defendants-Appellees.

Appeal from the United States District Court for the Southern District of California Anthony J. Battaglia, District Judge, Presiding

Argued and Submitted February 14, 2024 Pasadena, California

Filed March 25, 2024 ZENOFF V. SORRENTO THERAPEUTICS, INC.

Before: Richard C. Tallman and Consuelo M. Callahan, Circuit Judges, and Robert S. Lasnik,* District Judge.

Opinion by Judge Callahan

SUMMARY**

Securities Fraud

The panel affirmed the district court’s dismissal, for failure to state a claim, of an action alleging violations of the Securities Exchange Act and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.